Expert Perspectives on Unmet Needs and Emerging Solutions in PTCL Management

Peripheral T-cell lymphomas (PTCLs) present ongoing diagnostic and therapeutic challenges due to their biologic heterogeneity, evolving classification systems, and historically limited treatment durability. As advances in molecular characterization continue to refine PTCL subtypes and uncover new therapeutic targets, clinicians must increasingly integrate complex diagnostic and biomarker information into individualized, evidence-based treatment strategies, often in the context of relapsed or refractory (R/R) disease. This live, "Ask the Expert" webinar offers the opportunity to engage directly with nationally recognized PTCL experts who will translate emerging evidence into practical guidance. Through expert-led discussion and audience-driven Q&A, faculty will review updates on PTCL classification and guidelines, review current guideline recommendations across nodal PTCL subtypes, examine emerging data on novel treatment approaches, including targeted therapies and epigenetic modulators, and share strategies for aligning disease subtype and molecular features with therapeutic selection and clinical trial opportunities. By attending, learners will gain practical, immediately applicable insights to support more confident decision-making in both frontline and R/R PTCL settings.